MU
22
-6
DLTR
22
-10
ORLY
60
-5
NTRS
32
-12
VLO
26
-13
EOG
43
-2
LMT
45
-5
KLAC
50
-4
IR
52
-6
KSS
42
-4
AIZ
69
-4
AES
37
-3
RF
50
-3
SLB
39
-3
GOOGL
39
-8
SYY
60
-2
AAPL
36
-6
JNJ
48
-5
MCHP
32
-6
PSA
63
3
MU
22
-6
DLTR
22
-10
ORLY
60
-5
NTRS
32
-12
VLO
26
-13
EOG
43
-2
LMT
45
-5
KLAC
50
-4
IR
52
-6
KSS
42
-4
AIZ
69
-4
AES
37
-3
RF
50
-3
SLB
39
-3
GOOGL
39
-8
SYY
60
-2
AAPL
36
-6
JNJ
48
-5
MCHP
32
-6
PSA
63
3
Financhill
Back

Krystal Biotech Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
31

KRYS
Krystal Biotech

Last Price:
184.19
Seasonality Move:
19.58%
Sell
48

BMRN
Biomarin Pharmaceutical

Last Price:
84.10
Seasonality Move:
4.73%
Sell
31
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $184.19. The Score for KRYS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $84.11. The Score for BMRN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $184.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $84.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.3 Sell
Relative Strength Index (14 RSI): 40.33 Sell
Chaikin Money Flow: -1761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (182.69 - 198.89) Sell
Bollinger Bands (100): (162.53 - 197.21) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 36.77 Sell
Chaikin Money Flow: -846899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.03 - 92.05) Sell
Bollinger Bands (100): (79.6 - 88.86) Sell

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 191.95 Sell
20-day SMA: 193.18 Sell
50-day SMA: 194.51 Sell
200-day SMA: 157.56 Buy
8-day EMA: 189.95 Sell
20-day EMA: 192.59 Sell
50-day EMA: 190.42 Sell
200-day EMA: 163.59 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.25 Sell
20-day SMA: 90.01 Sell
50-day SMA: 86.4 Sell
200-day SMA: 87.4 Sell
8-day EMA: 88.27 Sell
20-day EMA: 88.8 Sell
50-day EMA: 87.14 Sell
200-day EMA: 86.74 Sell

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.86 per share, an increase next quarter of $0.49 per share, an increase this year of $3.98 per share, and an increase next year of $2.05 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.29 per share, an increase this year of $1.20 per share, and an increase next year of $1.04 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):